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of 0.68–0.88. Scores correlated significantly with frequency
of migraines in the past month and use of prophylactic
medications daily (both p  0.0001). Correlation of the
QOLWM and HDI total scores for the 728 people who
completed both questionnaires was 0.73. Item correlations
with the HDI total score were 0.47–0.67, demonstrating
external criterion validity. Additional studies are ongoing
to assess reproducibility and responsiveness.
CONCLUSIONS: These data demonstrate the psychomet-
ric properties of the QOLWM. The brief questionnaire may
be useful as a screening tool for clinicians to evaluate the im-
pact of migraine on individuals. The two-dimensional ap-
proach to patient-reported quality of life allows individuals
to weight the impact of both frequency and bothersomeness
of chronic migraines on multiple aspects of daily life.
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OBJECTIVE: Describe relationships between changes in
work outcomes (WO) and changes in asthma severity
over a one-year period.
METHODS: This longitudinal study surveyed adults en-
rolled in a managed care organization using identical
mailed surveys. 106 respondents completed both the 1997
and 1998 questionnaires and reported working outside the
home. Self-reported WO included missed work days due
to asthma and work performance (WP) from the Func-
tional Status Questionnaire, a 6-item scale using a 4-point
Likert scale, transformed to a 100 point scale. A 4-week
time reference was used. Perceived severity was determined
by asking patients their perceived severity on a 5-point
scale from very mild to very severe; evaluated severity was
based on reported symptoms matched to national guide-
lines. Respondents were grouped by change in asthma se-
verity: improvement; no change; or decline of at least one
severity category. Analysis included descriptive statistics,
paired Student’s t-test, and McNemer’s test.
RESULTS: Initially, respondent’s mean age was 44.4
(10.9) years; 72 (68.6%) were female; 76.7% had an an-
nual family income of 
$40,000; 96.2% were Caucasian;
and 76.4% had some college education or more; 42.9%
perceived their asthma severity as very mild or mild,
38.1% moderate, and 19.1% as severe or very severe.
Based on symptoms, 32.4% were classified as intermittent
mild, 28.6% mild persistent, 36.2% moderate, and 2.9%
severe asthma. WP scores changed in the expected direc-
tion based on changes in asthma severity: no change in
perceived severity (n  58) had no significant change in
WP score (91.3  13.0 versus 92.9  12.4, p  0.52); im-
provement in perceived severity (less severe, n  17) had
improved WP scores (91.8  7.9 versus 94.4  9.4, p 
0.30); and worsening of perceived severity (n  26) had a
decline in WP score (94.4  8 versus 91.3  10.9, p 
0.07). WP score trends were similar based on evaluated se-
verity. There were no significant differences in changes in
the number of respondents who reported missing work.
CONCLUSIONS: Changes in WP are related to asthma
severity. The measure of missed days work is less consis-
tently related.
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OBJECTIVES: To study the incidence of medical events
and resource utilisation in patients treated for severe cancer
pain with strong opioids with the general practitioner (GP).
METHODS: We analyzed data on 2,323 cancer patients
who switched from a weak to a strong opioid. Patients
started either on TTS Fentanyl (TTS: N  270), Immedi-
ate Release Morphine (IR: N  1,909) or Sustained Re-
lease Morphine (SR: N  144). We compared the medi-
cal events during their pain treatment, the number of
patients receiving concomitant medication and the num-
ber of GP visits. A descriptive analysis was performed as
well as relative risks (RR) calculated, adjusting for rele-
vant co-variates.
RESULTS: The groups were comparable for age (avg. 68
yrs). There were more female patients in the TTS group
(61.5%) compared to 48.1% and 49.3% for IR and SR,
respectively. Median duration of cancer prior to the start
of strong opioids was 7.1 months for TTS, 6 for IR and
5.3 for SR. Mean duration of treatment: 68 days for TTS,
97 for IR and 92 for SR. No differences in concomitant
illnesses were observed except for cancer types with sig-
nificantly more GI and fewer lung cancers in the TTS
group. Compared to TTS, patients on IR had more con-
stipation (RR 1.49: 95% CI 1.14–1.94), more nausea
and vomiting (RR 1.43: 95% CI 1.09–1.88) and more
cardiac events (RR 1.95: 95% CI 1.15–3.29), while SR
patients differed from TTS only with respect to cardiac
events (RR 2.79: 95% CI 1.49–5.22). IR patients had
also a higher rate of hospitalizations (RR 1.95: 95% CI
1.14–3.31) and GP visits (RR 1.21: 95% CI 0.98–1.49).
Fewer TTS patients consumed additional pain medica-
tion, laxatives as well as antibiotics and CNS medication.
CONCLUSION: This analysis of GP derived observa-
tional data indicate that TTS Fentanyl results in a lower
consumption of medication and other health care re-
sources compared to morphine treated cancer patients.
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